Physicochemical and microbiological stability studies of extemporaneous antihypertensive pediatric suspensions for hospital use

References

• Conroy S. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatr 2003;92:408–410.
   PubMed Web of Science ®Google Scholar
• Kayumba PC, Huyghebaert N, Cordella C, Ntawukuliryayo JD, Vervaet C, Remon JP. Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue. Eur J Pharm Biopharm 2007;66:460–465.
   PubMed Web of Science ®Google Scholar
• Freed AL, Silbering SB, Kolodsick KJ, Rossi DT, Mahjour M, Kingsmill CA. The development and stability assessment of extemporaneous pediatric formulations of Accupril. Int J Pharm 2005;304:135–144.
   PubMedGoogle Scholar
• Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164:552–558.
   PubMed Web of Science ®Google Scholar
• Strickley RG, Iwata Q, Wu S, Dahl TC. Pediatric drugs–a review of commercially available oral formulations. J Pharm Sci 2008;97:1731–1774.
   PubMed Web of Science ®Google Scholar
• Bosch ME, Sánchez AJ, Rojas FS, Ojeda CB. Recent advances in analytical determination of thalidomide and its metabolites. J Pharm Biomed Anal 2008;46:9–17.
   PubMedGoogle Scholar
• Rang HP, Ritter JM, Dale MM, eds. (2007). Farmacologia. Rio de Janeiro: Elsevier.
   Google Scholar
• Moffat AC, Osselton MD, Widdop B, eds. (2004). Clarke’s Analysis of Drugs and Poisons. , 3rd edition. London: Pharmaceutical Press.
   Google Scholar
• Khan N, Bakshi KS, Jaggi AS, Singh N. Ameliorative potential of spironolactone in diabetes induced hyperalgesia in mice. Yakugaku Zasshi 2009;129:593–599.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. (2006). Reflection Paper: Formulations of choice for the paediatric population.
   Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME, editors. (2009). Handbook of Pharmaceutical Excipients. 6th eds. London: Pharmaceutical Press.
   Google Scholar
• Kulshreshtha AK, Singh ON, Wall GM, eds. (2010). Pharmaceutical Suspensions. 13th edition. New York: Springer.
   Google Scholar
• British Farmacopoeia. (2009). 5th edition. London (England).
   Google Scholar
• Glass BD, Haywood A. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. J Pharm Pharm Sci 2006;9:398–426.
   PubMed Web of Science ®Google Scholar
• McRorie T. Quality drug therapy in children: formulations and delivery. Drug Inform J 1996;30:1173–1177.
   Google Scholar
• Basavaiah K, Chandrashekar U. Sensitive micro analysis of frusemide (furosemide) in bulk drug and formulations by visible spectrophotometry and high performance liquid chromatography (HPLC). Indian J Chem Tech 2005;12:405–406.
   Google Scholar
• The United States Pharmacopeial Convention. (2007). USP 30 Rockville, MD, USA: Inc.
   Google Scholar
• Tagliari MP, Stulzer HK, Murakami FS, Kuminek G, Valente B, Oliveira PR, et al. Development and validation of stability-indicating LC method to quantify hydrochlorothiazide in oral suspension for pediatric use. Chromatographia 2008;67:647–652.
   Google Scholar
• Martin A, Bustamante P, Chun AHC, eds. (2003). Physical Pharmacy. Philadelphia: Lea & Febiger.
   Google Scholar
• Farmacopéia Brasileira. (1988). São Paulo: Atheneu.
   Google Scholar
• Lieberman HL, Rieger MM, Banker GS, eds. (1996). Pharmaceutical Dosage Forms: Disperse Systems. 2nd edition. New York: Hardcover.
   Google Scholar
• Peeters J. Determination of ionization constants in mixed aqueous solvents of varying composition by a single titration. J Pharm Sci 1978;67:127–129.
   PubMed Web of Science ®Google Scholar
• Mollica JA, Rehm CR, Smith JB, Govan HK. Hydrolysis of benzothiadiazines. J Pharm Sci 1971;60:1380–1384.
   PubMed Web of Science ®Google Scholar
• Helin-Tanninen M, Naaranlahti T, Kontra K, Ojanen T. Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension. J Clin Pharm Ther 2001;26:59–66.
   PubMedGoogle Scholar
• Angel MJR, Agusti MTG, Romero JSE, Broch SC. Photodegradation and photostability studies of bendroflumethiazide (BFMT) in pharmaceutical formulations and urine samples by micellar liquid chromatography. LC GC Europe 2005;18:32–40.
   Google Scholar
• Yamana T, Mizukami Y, Tsuji A, Ichimura F. Studies on the stability of drugs. XX. Stability of benzothiadiazines. Studies on the hydrolysis of hydrochlorothiazide in the various pH solutions. Yakugaku Zasshi 1969;89:740–744.
   PubMedGoogle Scholar
• Deventer K, Baele G, Van Eenoo P, Pozo OJ, Delbeke FT. Stability of selected chlorinated thiazide diuretics. J Pharm Biomed Anal 2009;49:519–524.
   PubMedGoogle Scholar
• Li G, Zhang Y. Stereoselective synthesis of the two major metabolites of spironolactone, 3α- and 3β-hydroxy-7α-methylthio-17α-pregn-4-ene-21,17-carbolactone. Steroids 2007;72:569–572.
   PubMedGoogle Scholar
• Baka E, Comer JE, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 2008;46:335–341.
   PubMed Web of Science ®Google Scholar
• Cudina O, Karljikovic-rajic K, Ruvarac-bugarcic I, Jankovic I. Interaction of hydrochlorothiazide with cationic surfactant micelles of cetyltrimethylammonium bromide. Colloid Surface Physicochem Eng Aspect 2005;256:225–232.
   Google Scholar
• Vasconcelos CL, Dantas TN, Pereira MR, Fonseca JLC. Reology of concentrated alumina-polyelectrolyte systems. Colloid Polymer Sci 2004;282:596–601.
   Google Scholar
• Syroeshkin AV, Popov PI, Grebennikova TV, Frolov VA, Pleteneva TV. Laser diffraction for standardization of heterogeneous pharmaceutical preparations. J Pharm Biomed Anal 2005;37:927–930.
   PubMed Web of Science ®Google Scholar
• Han J, Beeton A, Long PF, Wong I, Tuleu C. Physical and microbiological stability of an extemporaneous tacrolimus suspension for paediatric use. J Clin Pharm Ther 2006;31:167–172.
   PubMed Web of Science ®Google Scholar
• Woods DJ. Extemporaneous formulations - problems and solutions. Paed Perinatal Drug Ther 1997;1:25–29.
   Google Scholar
• de la Rosa MC, Medina MR, Vivar C. Microbiological quality of pharmaceutical raw materials. Pharm Acta Helv 1995;70:227–232.
   PubMedGoogle Scholar
• Arndt C, Cruz MC, Cardenas ME, Heitman J. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology (Reading, Engl) 1999;145 (Pt 8):1989–2000.
   PubMedGoogle Scholar